These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10720203)

  • 21. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
    Grossman SA; Finkelstein DM; Ruckdeschel JC; Trump DL; Moynihan T; Ettinger DS
    J Clin Oncol; 1993 Mar; 11(3):561-9. PubMed ID: 8445432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
    Zwaveling J; den Hartigh J; Lankester AC; Guchelaar HJ; Egeler RM; Bredius RG
    Anticancer Drugs; 2006 Oct; 17(9):1099-105. PubMed ID: 17001185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
    Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
    J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.
    Shvidel L; Sigler E; Haran M; Klepfish A; Duek A; Berrebi A; Shtalrid M
    Leukemia; 2007 Sep; 21(9):2071-2. PubMed ID: 17611572
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
    Cole BF; Glantz MJ; Jaeckle KA; Chamberlain MC; Mackowiak JI
    Cancer; 2003 Jun; 97(12):3053-60. PubMed ID: 12784341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Busulfan dosing (Q6 or Q24) with adjusted or actual body weight, does it matter?
    Clemmons AB; Evans S; DeRemer DL; Awan FT
    J Oncol Pharm Pract; 2015 Dec; 21(6):425-32. PubMed ID: 24986792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea.
    Douglas G; Harrison C; Forsyth C; Bennett M; Stevenson W; Hounsell J; Ratnasingam S; Ritchie D; Ross DM; Grigg A
    Leuk Lymphoma; 2017 Jan; 58(1):89-95. PubMed ID: 27454522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL; Buhk JH; Strik H
    Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal topotecan in adult patients with neoplastic meningitis.
    Gammon DC; Bhatt MS; Tran L; Van Horn A; Benvenuti M; Glantz MJ
    Am J Health Syst Pharm; 2006 Nov; 63(21):2083-6. PubMed ID: 17057045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily Intravenous Infusion of Busulfan Impurity 5 for 4 Days Is Not Associated With Toxic Effects in the Rat.
    Bothe MK; Franckenstein D; Cade D; Quatresous E; Westphal M
    Int J Toxicol; 2020; 39(1):39-44. PubMed ID: 31777300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
    Jaeckle KA; Batchelor T; O'Day SJ; Phuphanich S; New P; Lesser G; Cohn A; Gilbert M; Aiken R; Heros D; Rogers L; Wong E; Fulton D; Gutheil JC; Baidas S; Kennedy JM; Mason W; Moots P; Russell C; Swinnen LJ; Howell SB
    J Neurooncol; 2002 May; 57(3):231-9. PubMed ID: 12125986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance chemotherapy with oral treosulfan following first-line treatment in patients with advanced ovarian cancer: feasibility and toxicity.
    Meden H; Wittkop Y; Kuhn W
    Anticancer Res; 1997; 17(3C):2221-3. PubMed ID: 9216692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation.
    Ansari M; Théoret Y; Rezgui MA; Peters C; Mezziani S; Desjean C; Vachon MF; Champagne MA; Duval M; Krajinovic M; Bittencourt H;
    Ther Drug Monit; 2014 Feb; 36(1):93-9. PubMed ID: 24061446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
    Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL).
    Fichtner I; Becker M; Baumgart J
    Eur J Cancer; 2003 Apr; 39(6):801-7. PubMed ID: 12651206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
    Heimberger AB; Archer GE; McLendon RE; Hulette C; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2000 Oct; 6(10):4148-53. PubMed ID: 11051269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
    Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.
    Bitan M; Or R; Shapira MY; Resnick IB; Ackerstein A; Samuel S; Elad S; Slavin S
    Haematologica; 2005 Aug; 90(8):1089-95. PubMed ID: 16079108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
    Glantz MJ; Cole BF; Recht L; Akerley W; Mills P; Saris S; Hochberg F; Calabresi P; Egorin MJ
    J Clin Oncol; 1998 Apr; 16(4):1561-7. PubMed ID: 9552066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation.
    Tran H; Petropoulos D; Worth L; Mullen CA; Madden T; Andersson B; Choroszy M; Nguyen J; Webb SK; Chan KW
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):805-12. PubMed ID: 15505611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.